inpremzia
baxter holding b.v. - insulin human (rdna) - sykursýki - lyf notuð við sykursýki - inpremzia is indicated for the treatment of diabetes mellitus.
dailiport hart forðahylki 5 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 5 mg
sandimmun innrennslisþykkni, lausn 50 mg/ml
novartis healthcare a/s - ciclosporinum inn - innrennslisþykkni, lausn - 50 mg/ml
humulin nph kwikpen stungulyf, dreifa í áfylltum lyfjapenna 100 a.e./ml
eli lilly danmark a/s - insulin human - stungulyf, dreifa í áfylltum lyfjapenna - 100 a.e./ml
dailiport hart forðahylki 0,5 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 0,5 mg
dailiport hart forðahylki 1 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 1 mg
dailiport hart forðahylki 2 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 2 mg
dailiport hart forðahylki 3 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 3 mg
prograf hart hylki 0,5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg
prograf hart hylki 1 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg